Induction sirolimus and delayed graft function after deceased donor kidney transplantation in the United States

American Journal of Nephrology

Volumn 24, Issue 4, 2004, Pages 393-401

  Simon, James F ^a,b   Swanson, S John ^a,c   Agodoa, Lawrence Y C ^c   Cruess, David F ^b   Bohen, Erin M ^a,b   Abbott, Kevin C ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Deceased donor kidney transplantation; Delayed graft function; Sirolimus

Indexed keywords

RAPAMYCIN;

ADULT; AGE DISTRIBUTION; ANOXIA; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; FEMALE; GRAFT FAILURE; HEMODIALYSIS; HEPATITIS C; HLA MATCHING; HUMAN; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RACE DIFFERENCE; RECIPIENT; RETROSPECTIVE STUDY; SEX DIFFERENCE; UNITED STATES;

ADULT; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS; UNITED STATES;

EID: 4644360727     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079734     Document Type: Article

References (24)

1. Flechner SM, Goldfarb D, Modlin C, Feng J, Krishnamurthi V, Mastrioanni B, Savas K, Cook DJ, Novick AC: Kidney transplantation without calcineurin inhibitor drugs: A prospective, randomized trial of sirolimus versus cyclosporine. Transplantation 2002;74:1070-1076.
2. Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP: Improved kidney function in sirolimus-treated kidney transplant patients after early cyclosporine elimination. Transplantation 2002;74:1560-1567.
3. MacDonald AS for the Rapamune Global Study Group: A worldwide phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001;71:271-280.
4. Kahan BD: Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomized multicentre study. Lancet 2000;356:194-202.
5. McTaggart RA, Gottlieb D, Brooks J, Bacchetti P, Toberts JP, Tomlanovich S, Feng S: Sirolimus prolongs recovery from delayed graft function after deceased donor kidney transplantation. Am J Tranplant 2003;3:416-423.
6. Stallone G, di Paola S, Schena A, Infante B, Battaglia M, DiTonno P, Gesualdo L, Grandaliano G, Schena FP: Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function. J Am Soc Nephrol 2004;15:228-233.
7. Smith KD, Wrenshall LE, Nicosia RF, Pichler R, Marsh CL, Alpers CE, Polissar N, Davis CL: Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol 2003;14:1037-1045.
8. Lawsin L, Light J: Severe acute kidney failure after exposure to sirolimus-tacrolimus in two living donor kidney recipients. Transplantation 2003;75:157-160.
9. Lieberthal W, Fuhro R, Andry CC, Rennke H, Abernathy VE, Koh JS, Valeri R, Levine JS: Rapamycin impairs recovery from acute kidney failure: Role of cell-cycle arrest and apoptosis of tubular cells. Am J Kidney Physiol 2001;281:F693-F706.
10. Inman SR, Davis NA, Olson KM, Lukaszek VA, McKinley MR, Seminerio JL: Rapamycin preserves kidney function compared with cyclosporine A after ischemia/reperfusion injury. Urology 2003;62:750-754.
11. Irish WD, McCollum DA, Tesi RJ, Owen AB, Brennan DC, Bailly JE, Schnitzler MA: Nomogram for predicting the likelihood of delayed graft function in adult deceased donor kidney transplant recipients. J Am Soc Nephrol 2003;14:2967-2974.
12. Bleyer AJ, Burkart JM, Russell GB, Adams PL: Dialysis modality and delayed graft function after deceased donor kidney transplantation. J Am Soc Nephrol 1999;10:154-159.
13. Abbott KC, Bucci JR, Matsumoto CS, Swanson SJ, Agodoa LY, Holtzmuller KC, Cruess DF, Peters TG: Hepatitis C and renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol 2003;14:2908-2918.
14. United States Kidney Data System. Available at: http://www.usrds.org, accessed 11/20/2003.
15. Bruemmer D, Yin F, Liu J, Kiyono T, Fleck E, Van Herle AJ, Law RE: Rapamycin inhibits E2F-dependent expression of minichromosome maintenance proteins in vascular smooth muscle cells. Biochem Biophys Res Commun 2003;303:251-258.
16. Henry ML, Pelletier RP, Elkhammas EA, Bumgardner GL, Davies EA, Ferguson RM: A randomized prospective trial of OKT3 induction in the current immunosuppression era. Clin Transplant 2001;15:410-414.
17. Meier-Kriesche HU, Arndorfer JA, Kaplan B: Association of antibody induction with shortand long-term cause-specific mortality in renal transplant recipients. J Am Soc Nephrol 2002;13:769-772.
18. Goggins WC, Pascual MA, Powelson JA, Magee C, Tolkoff-Rubin N, Farrell ML, Ko DS, Williams WW, Chandraker A, Delmonico FL, Auchincloss H, Cosimo AB: A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003;76:798-802.
19. Swanson SJ, Hale DA, Mannon RB, Kleiner DE, Cendales LC, Chamberlain CE, Polly SM, Harlan DM, Kirk AD: Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet 2002;360:1662-1664.
20. van Hooff JP, Squifflet JP, Wlodarczyk Z, Vanrenterghem Y, Paczek L: A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. Transplantation 2003;75:1934-1939.
21. Oberbauer R, Kreis H, Johnson RW, Mota A, Claesson K, Ruiz JC, Wilczek H, Jamieson N, Henriques AC, Chapman J, Burke JT: Rapamune Maintenance Regimen Study Group: Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study. Transplantation 2003;76:364-370.
22. Ciancio G, Burke GW, Gaynor JJ, Mattiazzi A, Roth D, Kupin W, Nicolas M, Ruiz P, Rosen A, Miller J: A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. Transplantation 2004;77:244-251.
23. Ciancio G, Burke GW, Gaynor JJ, Mattiazzi A, Roth D, Kupin W, Nicolas M, Ruiz P, Rosen A, Miller J: A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. Transplantation 2004;77:252-258.
24. Kreis H, Oberbauer R, Campistol JM, Mathew T, Daloze P, Schena FP, Burke JT, Brault Y, Gioud-Paquet M, Scarola JA, Neylan JF: Longterm benefits with sirolimus-based therapy after early cyclosporine withdrawal. J Am Soc Nephrol 2004;15:809-817.